Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis Sells 1,498 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis sold 1,498 shares of the company’s stock in a transaction on Friday, April 26th. The stock was sold at an average price of $369.92, for a total transaction of $554,140.16. Following the sale, the executive vice president now directly owns 5,507 shares of the company’s stock, valued at $2,037,149.44. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Robert Desantis also recently made the following trade(s):

• On Monday, April 29th, Robert Desantis sold 376 shares of Intuitive Surgical stock. The stock was sold at an average price of $375.39, for a total value of $141,146.64.
• On Monday, March 11th, Robert Desantis sold 329 shares of Intuitive Surgical stock. The shares were sold at an average price of $390.16, for a total transaction of $128,362.64.
• On Friday, March 8th, Robert Desantis sold 20,296 shares of Intuitive Surgical stock. The shares were sold at an average price of $393.80, for a total transaction of $7,992,564.80.

Intuitive Surgical Price Performance

NASDAQ ISRG traded down $3.52 on Tuesday, hitting $370.62. 1,204,415 shares of the stock were exchanged, compared to its average volume of 1,637,873. The company’s 50-day moving average price is $386.10 and its two-hundred day moving average price is $347.50. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $403.76. The company has a market capitalization of $131.46 billion, a price-to-earnings ratio of 67.53, a P/E/G ratio of 4.85 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. The firm had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The business’s quarterly revenue was up 11.5% compared to the same quarter last year. During the same period last year, the company posted $1.00 EPS. Equities analysts predict that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have recently weighed in on ISRG. Royal Bank of Canada raised their target price on Intuitive Surgical from $400.00 to $432.00 and gave the company an “outperform” rating in a research note on Wednesday, January 24th. StockNews.com downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Barclays increased their price target on Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a research report on Thursday, January 25th. Stifel Nicolaus boosted their target price on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, April 8th. Finally, Robert W. Baird lowered their price target on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a report on Friday, April 19th. Five equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $396.17.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in ISRG. Brookstone Capital Management boosted its position in Intuitive Surgical by 277.7% during the third quarter. Brookstone Capital Management now owns 7,259 shares of the medical equipment provider’s stock valued at $1,985,000 after purchasing an additional 5,337 shares during the last quarter. Commonwealth Equity Services LLC lifted its holdings in shares of Intuitive Surgical by 10.9% during the 3rd quarter. Commonwealth Equity Services LLC now owns 61,148 shares of the medical equipment provider’s stock valued at $17,873,000 after buying an additional 6,018 shares during the last quarter. RMR Wealth Builders lifted its stake in Intuitive Surgical by 66.5% in the third quarter. RMR Wealth Builders now owns 4,076 shares of the medical equipment provider’s stock valued at $1,191,000 after acquiring an additional 1,628 shares during the last quarter. Accurate Wealth Management LLC grew its position in Intuitive Surgical by 4.1% in the third quarter. Accurate Wealth Management LLC now owns 5,094 shares of the medical equipment provider’s stock worth $1,403,000 after acquiring an additional 199 shares in the last quarter. Finally, Balboa Wealth Partners increased its stake in shares of Intuitive Surgical by 3.3% during the 3rd quarter. Balboa Wealth Partners now owns 5,619 shares of the medical equipment provider’s stock worth $1,642,000 after purchasing an additional 180 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.